No Detail Found!

Effect of ABCB1 polymorphism on the clinical outcome of osteosarcoma patients after receiving chemotherapy.

Author(s)
Sun Xiaohui Department of Orthopedic Surgery, The first affiliated Hospital of Xinxiang Medical University, Weihui, Henan, China
Li Aiguo Department of Orthopedic Surgery, The first affiliated Hospital of Xinxiang Medical University, Weihui, Henan, China
Geng Xiaolin Department of Orthopedic Surgery, The first affiliated Hospital of Xinxiang Medical University, Weihui, Henan, China
Liu Ying Department of Obstetrics and Gynecology, The first affiliated Hospital of Xinxiang Medical University, Weihui, Henan, China
Zhao Hongxing Department of Orthopedic Surgery, The first affiliated Hospital of Xinxiang Medical University, Weihui, Henan, China
Zhao Yilei Department of Orthopedic Surgery, The first affiliated Hospital of Xinxiang Medical University, Weihui, Henan, China
Abstract
Objective: To investigate the role of three genetic polymorphisms of ABC proteins in response to chemotherapy and overall survival of osteosarcoma patients. Methods: A prospective study was conducted. Genotyping analyses of ABCB1 C3435T, ABCG2 C421A, and ABCC3 C-211T were conducted using the TaqMan methodology. Multivariate Cox proportional hazards models were used to calculate hazard ratio (HR) and 95% CI of effect of each genotype of ABCB1 C3435T, ABCG2 c421A, and ABCC3 C-211T on PFS and OS. Results: During the follow-up period, 135 patients (74.18%) were alive and 47 died (25.82). The median follow-up periods were 36.7 months. Individuals carrying with ABCB1 3435TT genotype and T allele showed less likely to have a poor response to chemotherapy. Cox regression analysis showed that individuals with ABCB1 TT genotype and T allele were associated with high risk of death from osteosarcoma when compared with wide-type genotype. However, we did not find significant association between ABCG2 C421A and ABCC3 C-211T polymorphisms and overall survival of osteosarcoma. Conclusion: ABCB1 C3435T polymorphism may be used as a genetic predictor of clinical outcome in osteosarcoma patients treated with chemotherapy. However, no association was found between polymorphisms in ABCG2 C421A and ABCC3 C-211T and clinical outcome of osteosarcoma.
Publication Details
Page(s) 886-890
DOI DOI not available
Published Journal: Pakistan Journal of Medical Sciences, Volume: 30, Issue: 4, Year: 2014

Request the full text from PASTIC

0

Citations

0

Downloads

64

Views